A draft of an executive order detailing changes to the pharmaceutical industry has been obtained by journalists. In the document, President Trump outlines much of his earlier proposals to the industry in January. Namely, the document cites streamlined approval...
ReWalk Robotics has released a softsuit exoskeleton designed for stroke victims. The suit uses motor operated knee joints and hips to enable survivors to stand and walk once again. The device, named Restore, works similarly to the company’s prior device, ReWalk (named...
Shire has announced the recent FDA approval for its Adderall iteration, Mydayis. The drug, which was denied approval by the FDA nearly a decade ago, was finally approved this week following the inspection of 16 clinical studies. Both adults and children were included...
Neos Therapeutics announces this week the recent approval of its pediatric ADHD medication, Cotempla. The medication is approved for use in children ages 6-17 years old. The tablet is an extended-release product which dissolves in the mouth, making regular use easier...
Anthem has announced plans to reduce the amount of individual plans it offers in Wisconsin and Indiana. The insurer’s plans to exit the Affordable Care Act in these states is cited as a result of legislative uncertainty and a lack of cost sharing reductions from the...
